Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merav Fraenkel

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
NPJ Breast Cancer|July 20, 2017
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysisMerav Fraenkel, David B Geffen, Victor Novack, et al.
Plos One|August 14, 2013
Association between bone mineral density and incidence of breast cancerMerav Fraenkel, Victor Novack, Yair Liel, et al.
Endocrine|May 23, 2022
Resistant prolactinomas: a case series of 26 patientsTamar Eshkoli, Merav Fraenkel, Dana Zaid, et al.
Cancer|March 23, 2011
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomasSimona Grozinsky-Glasberg, Dganit Barak, Merav Fraenkel, et al.
Endocrine Pathology|October 11, 2017
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell AdenomasJulieann C Lee, Melike Pekmezci, Jonathan L Lavezo, et al.
Diabetes|January 5, 2008
mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetesMerav Fraenkel, Mali Ketzinel-Gilad, Yafa Ariav, et al.
JBMR Plus|September 29, 2025
Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutationChen Abramovitch-Dahan, Svetlana Katchkovsky, Yuval Zur, et al.
Clinical Nuclear Medicine|December 14, 2011
Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patternsYodphat Krausz, Rina Rubinstein, Liat Appelbaum, et al.
World Journal of Gastroenterology|January 1, 2014
Metastatic type 1 gastric carcinoid: a real threat or just a myth?Simona Grozinsky-Glasberg, Dimitrios Thomas, Jonathan R Strosberg, et al.
Endocrine|June 3, 2019
Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 yearsIlan Shimon, Dania Hirsch, Gloria Tsvetov, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
NPJ Breast Cancer|July 20, 2017
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysisMerav Fraenkel, David B Geffen, Victor Novack, et al.
Plos One|August 14, 2013
Association between bone mineral density and incidence of breast cancerMerav Fraenkel, Victor Novack, Yair Liel, et al.
Endocrine|May 23, 2022
Resistant prolactinomas: a case series of 26 patientsTamar Eshkoli, Merav Fraenkel, Dana Zaid, et al.
Cancer|March 23, 2011
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomasSimona Grozinsky-Glasberg, Dganit Barak, Merav Fraenkel, et al.
Endocrine Pathology|October 11, 2017
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell AdenomasJulieann C Lee, Melike Pekmezci, Jonathan L Lavezo, et al.
Diabetes|January 5, 2008
mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetesMerav Fraenkel, Mali Ketzinel-Gilad, Yafa Ariav, et al.
JBMR Plus|September 29, 2025
Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutationChen Abramovitch-Dahan, Svetlana Katchkovsky, Yuval Zur, et al.
Clinical Nuclear Medicine|December 14, 2011
Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patternsYodphat Krausz, Rina Rubinstein, Liat Appelbaum, et al.
World Journal of Gastroenterology|January 1, 2014
Metastatic type 1 gastric carcinoid: a real threat or just a myth?Simona Grozinsky-Glasberg, Dimitrios Thomas, Jonathan R Strosberg, et al.
Endocrine|June 3, 2019
Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 yearsIlan Shimon, Dania Hirsch, Gloria Tsvetov, et al.
Pageof 5